Switch from prednisone to dexamethasone in patients with metastatic castration resistant prostate cancer (mCRPC) treated with abiraterone acetate (AA) in a multicenter study
2018 ◽
Vol 14
(3)
◽
pp. 233-238
◽
2021 ◽
Vol 37
(4)
◽
pp. 635-642
2015 ◽
Vol 45
(8)
◽
pp. 774-779
◽